The Federal Trade Commission is stepping up its crackdown on so-called "junk patents," which it contends are ploys intended ...
The FTC intensifies efforts against pharmaceutical patent listings, disputing junk patents for diabetes, weight loss, asthma, ...
This follows a similar move the FTC made in November involving 100 patents filed by pharma companies. The latest spate of “junk patent” listings include medicines for diabetes, asthma, COPD, and ...
disputing the accuracy of some 300 patent listings in the Food and Drug Administration’s so-called “Orange Book.” The crackdown, which comes six months after FTC challenged 10 pharma majors in a ...
Boehringer Ingelheim, one of 10 companies sent a warning letter by the FTC disputing the accuracy of patent listings in the ...
※ 商品のお届けについてはこちらよりご確認ください。 SHOPPINGが販売、発送いたします。 当日発送可 (14:00までのご注文が対象) ご注文内容・出荷状況によっては当日発送できない場合もございます。 詳しくはこちらよりご確認ください。 利用可 ポストに ...